Bellerophon Therapeutics (BLPH) Enrolls First Patient in Phase 3 INOvation-1

June 16, 2016 6:05 AM EDT Send to a Friend
Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) announced that the first subject has been enrolled in the Phase 3 INOvation-1 clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login